Tomohide Tsukahara

18PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomaterialsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 21, 2025
Effect of human survivin-2B-specific cytotoxic CD8+ T lymphocytes on CD44+/- HSC-2 and HSC-3 oral cancer cells.

Sho Miyamoto, Azuna Osaki, Aiko Murai

|Nov 22, 2023
Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5.

Asaka Wada, Yoshihiko Hirohashi, Goro Kutomi

|Oct 25, 2023
Development of T cell receptor-engineered T cells targeting the sarcoma-associated antigen papillomavirus binding factor.

Shuto Hamada, Tomohide Tsukahara, Yuto Watanabe

|Jun 22, 2023
Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy.

Sho Miyamoto, Yoshihiko Hirohashi, Rena Morita

|Mar 23, 2023
Metastatic pulmonary pleomorphic carcinoma replaced by a granulomatous lesion after spontaneous regression and PD-1 blockade-induced regression: can epithelioid granuloma be a histological hallmark of cancer immunity?

Naoki Shijubou, Yuichiro Asai, Michiko Hosaka

|Dec 16, 2022
Development of CAR-T cells specifically targeting cancer stem cell antigen DNAJB8 against solid tumours.

Yuto Watanabe, Tomohide Tsukahara, Kenji Murata

Pageof 3

Frequent Collaborators

12 joint publications

Yoshihiko Hirohashi

5 joint publications

Terufumi Kubo

5 joint publications

Takayuki Kanaseki

2 joint publications

Akihiro Miyazaki